Latest Administration News

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

AUCyber Limited reported a decline in Q3 FY25 cash receipts amid strategic rationalisation and a completed takeover by 5G Networks Limited, which now controls nearly 90% of shares. The company also refreshed its leadership and raised $2.75 million through an entitlement offer.

Li-S Energy Limited reported solid progress in its March 2025 quarter, advancing a key collaboration with Kea Aerospace to integrate lithium-sulfur batteries into high-altitude UAVs, while strengthening its board and maintaining a healthy cash position.

Visionflex Group Limited reported a net cash outflow of AUD 1.34 million for Q1 2025, maintaining liquidity through convertible note facilities that extend funding runway to over two quarters.

CurveBeam AI Limited reported a $4.367 million net operating cash outflow for Q3 2025 but anticipates a significant improvement in cash flow driven by device installations and customer receipts, with no immediate plans for capital raising.

Amplia Therapeutics has completed recruitment early for its Phase 2a ACCENT trial in advanced pancreatic cancer, reporting encouraging interim results and advancing a second trial with FDA-backed protocol changes.

Australian Critical Minerals reports significant high-grade iron ore discoveries at its Pilbara Shaw and Cooletha projects, while strategically withdrawing from rare earths to concentrate on iron assets.

Hot Chili Limited has achieved priority project registration for its Costa Fuego and Huasco Water copper-gold developments in Chile, unlocking streamlined government approvals and reinforcing its strategic growth trajectory.

Titanium Sands Limited has secured the Terms of Reference for the Environmental Impact Assessment of its Mannar Heavy Mineral Project, marking a pivotal regulatory milestone. The company is also progressing tenure retention applications amid plans for further capital raising.

Alchemy Resources Limited reported a modest net cash outflow in operating activities for Q1 2025 but ended the quarter with a robust cash balance supporting over 17 quarters of funding.

Argenica Therapeutics has completed patient dosing in its Phase 2 trial of ARG-007 for acute ischaemic stroke, with topline data expected in Q3 2025. The company also plans to submit its Investigational New Drug application and Fast Track request to the FDA imminently.

PVW Resources reports strong drilling results at its Capão Bonito rare earth project in Brazil, with Total Rare Earth Oxide grades reaching up to 3,267 ppm, while preparing for further exploration campaigns across its Brazilian hubs.